JS111

· Suzhou Junjing BioSciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JS111, covering 2025-05-14 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study [Phase 2]